title: Contribution of BRCA2 germline mutations to hereditary breast/ovarian cancer in Germany.
authors.forename: U
authors.initials: U
authors.lastname: Hamann
authors.forename: X
authors.initials: X
authors.lastname: Liu
authors.forename: S
authors.initials: S
authors.lastname: Lange
authors.forename: H U
authors.initials: HU
authors.lastname: Ulmer
authors.forename: A
authors.initials: A
authors.lastname: Benner
authors.forename: R J
authors.initials: RJ
authors.lastname: Scott
mesh_terms: D000328:Adult; D017668:Age of Onset; D000368:Aged; D001943:Breast Neoplasms / Q000453:epidemiology / Q000235:genetics* / Q000473:pathology; D004252:DNA Mutational Analysis; D005091:Exons / Q000235:genetics; D005260:Female; D005787:Gene Frequency; D019398:Genes, BRCA1; D024522:Genes, BRCA2; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D005820:Genetic Testing; D018095:Germ-Line Mutation / Q000235:genetics*; D005858:Germany / Q000453:epidemiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000453:epidemiology / Q000235:genetics* / Q000473:pathology; D010375:Pedigree; D018807:Polymorphism, Single-Stranded Conformational